Allosensitization in bridge to transplant Novacor left ventricular assist device patients: analysis of long-term outcomes with regard to acute rejection and chronic allograft vasculopathy

European Journal of Cardio-thoracic Surgery

Volumn 34, Issue 2, 2008, Pages 268-274

  Kirsch, Lotti ^a   Timmermans, Thierry ^a   Van Caenegem, Olivier ^a   Gurne, Olivier ^a   Noirhomme, Philippe ^a   Jacquet, Luc Marie ^a   Latinne, Dominique ^a   Poncelet, Alain J ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

Allograft vasculopathy; Assist device; Rejection; Transplantation

Indexed keywords

HLA ANTIBODY; IMMUNOGLOBULIN G; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ACUTE GRAFT REJECTION; ADULT; ANTIBODY TITER; ARTICLE; ASSISTED CIRCULATION; CONTROLLED STUDY; DEVICE; FEMALE; FOLLOW UP; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; OVERALL SURVIVAL; PREVALENCE; PRIORITY JOURNAL; SENSITIZATION; VASCULAR DISEASE;

ADULT; AUTOANTIBODIES; CHRONIC DISEASE; CORONARY DISEASE; EPIDEMIOLOGIC METHODS; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; HEART-ASSIST DEVICES; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; HLA ANTIGENS; HUMANS; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 46749106281     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2008.03.063     Document Type: Article

References (25)

1. Taylor D.O., Edwards L.B., Boucek M.M., Trulock E.P., Aurora P., Christie J., Dobbels F., Rahmel A.O., Keck B.M., and Hertz M.I. Registry of the International Society for Heart and Lung Transplantation: twenty-fourth official adult heart transplant report - 2007. J Heart Lung Transplant 26 8 (2007) 769-781
2. Hosenpud J.D., Bennett L.E., Keck B.M., Boucek M.M., and Novick R.J. The Registry of the International Society for Heart and Lung Transplantation: seventeenth official report-2000. J Heart Lung Transplant 19 10 (2000) 909-931
3. Moazami N., Itescu S., Williams M.R., Argenziano M., Weinberg A., and Oz M.C. Platelet transfusions are associated with the development of anti-major histocompatibility complex class I antibodies in patients with left ventricular assist support. J Heart Lung Transplant 17 9 (1998) 876-880
4. Massad M.G., Cook D.J., Schmitt S.K., Smedira N.G., McCarthy J.F., Vargo R.L., and McCarthy P.M. Factors influencing HLA sensitization in implantable LVAD recipients. Ann Thorac Surg 64 4 (1997) 1120-1125
5. Ankersmit H.J., Tugulea S., Spanier T., Weinberg A.D., Artrip J.H., Burke E.M., Flannery M., Mancini D., Rose E.A., Edwards N.M., Oz M.C., and Itescu S. Activation-induced T-cell death and immune dysfunction after implantation of left ventricular assist device. Lancet 354 (1999) 550-555
6. Schuster M., Kocher A., John R., Hoffman M., Ankersmit J., Lietz K., Edwards N., Oz M., and Itescu S. B-cell activation and allosensitization after left ventricular assist device implantation is due to T-cell activation and CD40 ligand expression. Hum Immunol 63 3 (2002) 211-220
7. Kumpati G.S., Cook D.J., Blackstone E.H., Rajeswaran J., Abdo A.S., Young J.B., Starling R.C., Smedira N.G., and McCarthy P.M. HLA sensitization in ventricular assist device recipients: does type of device make a difference?. J Thorac Cardiovasc Surg 127 6 (2004) 1800-1807
8. Pagani F.D., Dyke D.B., Wright S., Cody R., and Aaronson K.D. Development of anti-major histocompatibility complex class I or II antibodies following left ventricular assist device implantation: effects on subsequent allograft rejection and survival. J Heart Lung Transplant 20 6 (2001) 646-653
9. John R., Lietz K., Schuster M., Naka Y., Rao V., Mancini D.M., Rose E.A., Smith C.R., Oz M.C., Edwards N.M., and Itescu S. Immunologic sensitization in recipients of left ventricular assist devices. J Thorac Cardiovasc Surg 125 3 (2003) 578-591
10. Baran D.A., Gass A.L., Galin I.D., Zucker M.J., Arroyo L.H., Goldstein D.J., Prendergast T., Lubitz S., Courtney M.C., Correa R., Chan M., Spielvogel D., and Lansman S.L. Lack of sensitization and equivalent post-transplant outcomes with the Novacor left ventricular assist device. J Heart Lung Transplant 24 11 (2005) 1886-1890
11. Loh E., Bergin J.D., Couper G.S., and Mudge Jr. G.H. Role of panel-reactive antibody cross-reactivity in predicting survival after orthotopic heart transplantation. J Heart Lung Transplant 13 2 (1994) 194-201
12. Kobashigawa J.A., Sabad A., Drinkwater D., Cogert G.A., Moriguchi J.D., Kawata N., Hamilton M.A., Hage A., Terasaki P., and Laks H. Pretransplant panel reactive-antibody screens. Are they truly a marker for poor outcome after cardiac transplantation?. Circulation 94 9 Suppl. (1996) II294-II297
13. Gonzalez-Stawinski G.V., Cook D.J., Chang A.S., Banbury M.K., Navia J.L., Hoercher K., Lober C., Atik F.A., Taylor D.O., Yamani M.H., Young J.B., Starling R.C., and Smedira N.G. Ventricular assist devices and aggressive immunosuppression: looking beyond overall survival. J Heart Lung Transplant 25 6 (2006) 613-618
14. Strauch J.T., Spielvogel D., Haldenwang P.L., Correa R.K., deAsla R.A., Seissler P.E., Baran D.A., Gass A.L., and Lansman S.L. Recent improvements in outcome with the Novacor left ventricular assist device. J Heart Lung Transplant 22 6 (2003) 674-680
15. Rose E.A., Smith C.R., Petrossian G.A., Barr M.L., and Reemtsma K. Humoral immune responses after cardiac transplantation: correlation with fatal rejection and graft atherosclerosis. Surgery 106 2 (1989) 203-207
16. Suciu-Foca N., Reed E., Marboe C., Harris P., Yu P.X., Sun Y.K., Ho E., Rose E.A., Reemtsma K., and King D.W. The role of anti-HLA antibodies in heart transplantation. Transplantation 51 3 (1991) 716-724
17. Aziz S., Hassantash S.A., Nelson K., Levy W., Kruse A., Reichenbach D., Himes V., Fishbein D., and Allen M.D. The clinical significance of flow cytometry crossmatching in heart transplantation. J Heart Lung Transplant 17 7 (1998) 686-692
18. Billingham M.E., Cary N.R., Hammond M.E., Kemnitz J., Marboe C., McCallister H.A., Snovar D.C., Winters G.L., and Zerbe A. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. The International Society for Heart Transplantation. J Heart Transplant 9 6 (1990) 587-593
19. Sharples L.D., Jackson C.H., Parameshwar J., Wallwork J., and Large S.R. Diagnostic accuracy of coronary angiography and risk factors for post-heart-transplant cardiac allograft vasculopathy. Transplantation 76 4 (2003) 679-682
20. Gonzalez-Stawinski G.V., Cook D.J., Chang A.S., Atik F., Navia J.L., Banbury M., Roselli E., Young J.B., Starling R.A., and Smedira N.G. Early and midterm risk of coronary allograft vasculopathy in patients bridged to orthotopic heart transplantation with ventricular assist devices. Transplantation 79 9 (2005) 1175-1179
21. Newell H., Smith J.D., Rogers P., Birks E., Danskine A.J., Fawson R.E., and Rose M.L. Sensitization following LVAD implantation using leucodepleted blood is not due to HLA antibodies. Am J Transplant 6 7 (2006) 1712-1717
22. Drakos S.G., Stringham J.C., Long J.W., Gilbert E.M., Fuller T.C., Campbell B.K., Horne B.D., Hagan M.E., Nelson K.E., Lindblom J.M., Meldrum P.A., Carlson J.F., Moore S.A., Kfoury A.G., and Renlund D.G. Prevalence and risks of allosensitization in HeartMate left ventricular assist device recipients: the impact of leukofiltered cellular blood product transfusions. J Thorac Cardiovasc Surg 133 6 (2007) 1612-1619
23. Itescu S., Tung T.C., Burke E.M., Weinberg A., Moazami N., Artrip J.H., Suciu-Foca N., Rose E.A., Oz M.C., and Michler R.E. Preformed IgG antibodies against major histocompatibility complex class II antigens are major risk factors for high-grade cellular rejection in recipients of heart transplantation. Circulation 98 8 (1998) 786-793
24. Spanier T.B., Chen J.M., Oz M.C., Stern D.M., Rose E.A., and Schmidt A.M. Time-dependent cellular population of textured-surface left ventricular assist devices contributes to the development of a biphasic systemic procoagulant response. J Thorac Cardiovasc Surg 118 3 (1999) 404-413
25. Tambur A.R., Pamboukian S.V., Costanzo M.R., Herrera N.D., Dunlap S., Montpetit M., and Heroux A. The presence of HLA-directed antibodies after heart transplantation is associated with poor allograft outcome. Transplantation 80 8 (2005) 1019-1025